The man who acquired Sound United and founded US Health Company Masimo has been sacked by his own board, and to top that that ...

A US Court hearing the case of Apple Vs Masimo appear to have given Apple a two finger salute by awarding them US$250, the ...

These are independent reviews of the products mentioned, but TIME receives a commission when purchases are made through ...

Masimo delivered Q3 results that mostly aligned with guidance, yet it faces challenges in its non-healthcare segment.

We recently published a list of 8 Most Promising Medical Stocks According to Hedge Funds. In this article, we are going to ...

Overall, even while funding for digital health had been rising gradually in ... by 150 percentage points (see more details here).” Masimo Corporation (NASDAQ:MASI) is a global medical technology ...

The consensus rating for Masimo is Buy, based on 2 analyst ratings. With an average one-year price target of $167.5, there's a potential 16.14% upside.

When compared to others in the Health Care sector, the company faces challenges, achieving a growth rate lower than the average among peers. Net Margin: Masimo's net margin is below industry ...

A Delaware jury has found smartwatch maker Masimo guilty of infringing Apple's Apple Watch patents on health technology, but ...